Aclarion Corporation (ACON) Business Payback Period

Corporate emblem and logo of Aclarion Corporation (ACON)

Historical price action for Aclarion (ACON) on the GURU.Markets platform demonstrates a value of -0.50, while the business struggles with liquidity shortages and slow product adoption by clinics. Aclarion revenues rely on the integration of MRI software into routine diagnostics, which has yet to guarantee sustainable cash flow. However, unique AI developments for identifying pain biomarkers provide the firm with the status of a technological visionary.

ACON: Aclarion, Inc. P/E Multiple 04/28/2023 - 11/11/2026

Analytical breakdowns for Aclarion Corp (ACON)

- market price and analyst price targets:
Market Price aclarion.com|ACON - Price Target Chart
- market capitalization details:
Market Capitalization Aclarion, Inc.|ACON - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Aclarion|ACON - Book Capitalization|Market Capitalization to Book Value aclarion.com|ACON - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Aclarion|ACON - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Aclarion Corporation|ACON - Company Debts|Debt to Book Value Aclarion, Inc.|ACON - Company Long-Term Debts|Short-Term Debt Aclarion|Immediate Liquidity Ratio aclarion.com
- earnings and valuation multiples information:
ACON - Net Profit|Company Profit Forecast Aclarion|ACON - P/E Multiple|Projected Price to Earnings Aclarion Inc|ACON - PEG Multiple|EV/EBITDA Multiple Aclarion, Inc.|ACON - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Aclarion|ACON - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months aclarion.com|ACON - Earnings growth in current year|Expected net earnings per share growth next year Aclarion
Comprehensive company analysis:ACON aclarion.com
Signature product of Aclarion Corporation

As a portfolio manager, I evaluate asset value through the ratio of market capitalization to net income. This P/E ratio for the company measures the investment payback period, demonstrating the extent of the premium paid for future earnings. The P/E ratio trend allows for the timely detection of asset overheating or stagnation. For Aclarion (ACON), this metric is critical due to the high margins of its cloud SaaS service. The scalability of MRI algorithms under fixed costs should rapidly reduce this indicator as the customer base grows.

Key competitors

Market Cap to Earnings abbott.com ABT|Price to Earnings Ratio Thermo Fisher (TMO)|Business Payback Period GE HealthCare Technologies Inc.|Mettler-Toledo International Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio WAT (Waters Technologies)|Bio-Techne Corporation - P/E Multiple|Business Payback Period bruker.com BRKR|AZTA: P/E Multiple|Price to Earnings Ratio Varex Imaging Corp|Price to Earnings Ratio SMLR|BFLY: Company Value to Net Income|Price to Earnings Ratio Mesa Laboratories, Inc. (MLAB)|Price to Earnings Ratio quantum-si.com QSI|P/E Multiple NNOX (Nano-X)|Quanterix Corp. (QTRX) - Market Cap to Earnings|908 Devices Corp - P/E Multiple|CV (CapsoVision Inc) - Price to Earnings Multiple|MXCT: P/E Multiple|RPID - Business Payback Period|SEER (Seer) - P/E Multiple|Price to Earnings Ratio Hyperfine Inc (HYPR)|P/E Multiple FONR|P/E Multiple daxor.com (DXR)|Price to Earnings Ratio Spectral AI MDAI|organovo.com - Price to Earnings Ratio|AKYA: Price to Earnings Ratio|Company Value to Net Income THMO (ThermoGenesis Holdings, Inc.)|TLIS: P/E Multiple|Market Cap to Earnings T2 Biosystems Inc (TTOO)